Jennifer A Foltz

16PUBLICATIONS
151CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Genome structure and regulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 10, 2026
Automating neoantigen selection for personalized cancer vaccine design.

|Jun 18, 2026
Inducible T-bet deletion reveals tissue-specific requirements in NKp46+ ILC immunobiology and response to murine cytomegalovirus.

|May 06, 2026
CD39+CD49a+CD103+ cytotoxic tissue-resident natural killer cells infiltrate and control solid epithelial tumor growth in mice.

|Mar 25, 2026
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Omar H Butt, Kartik Singhal, Jingqin Luo

|Apr 16, 2025
Mapping the spatial architecture of glioblastoma from core to edge delineates niche-specific tumor cell states and intercellular interactions.

Saad M Khan, Anthony Z Wang, Rupen R Desai

|Mar 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.

Alice Y Zhou, Nancy D Marin, Sadia Afrin

Pageof 3

Frequent Collaborators

9 joint publications

Todd A Fehniger

8 joint publications

Pamela Wong

7 joint publications

David Russler-Germain

7 joint publications

Obi L Griffith